Financial Statements · Financial Reporting

Narafarm OÜ

Official identifier 12139312Record date 31 Dec 2022
Estonia

Report

Legal form
OÜ
Report status
Registered

Dates

Reporting year
2022
Period start
1 Jan 2022
Submitted date
3 Jul 2023

Report

Consolidated
No
Audited
No

Financial metrics

StatementMetricValue
Bilanss, detailneAssets1,033,867
Bilanss, detailneCash and cash equivalents58,646
Bilanss, detailneCurrent assets167,858
Bilanss, detailneCurrent liabilities115,491
Bilanss, detailneEquity605,603
Bilanss, detailneShare capital at nominal value2,500
Bilanss, detailneNon-current assets866,009
Bilanss, detailneNon-current liabilities312,773
Bilanss, detailneRetained earnings (loss) from previous periods512,941
Income statement scheme 1Depreciation and impairment of non-current assets-94,544
Income statement scheme 1Labour costs-23,201
Income statement scheme 1Revenue369,229
Income statement scheme 1Annual period profit / loss89,912
Income statement scheme 1Operating profit (loss)100,001
Income statement scheme 1Profit (loss) before income tax89,912
Profit distribution proposalRetained earnings (loss) from previous periods512,941
Note: Labour costsEmployees2
Note: Labour costsLabour costs23,201

Linked company

Company: Narafarm OÜ

Source

Estonian e-Business Register Annual Reports open data

View published source

Back to Financial Statements